Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Archives of Medical Science : AMS|August 1, 2026
The use of prognostic scales in upper gastrointestinal tract bleedingCzesław Osuch, Mateusz Rubinkiewicz, Piotr Tylec, et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|August 12, 2005
Gastrointestinal stromal tumors. A multicenter experienceKatarzyna Urbańczyk, Janusz Limon, Elzbieta Korobowicz, et al.
Cell Transplantation|September 22, 2017
Crossing Anatomic Barriers-Transplantation of a Kidney with 5 Arteries, Duplication of the Pyelocalyceal System, and Double UreterPiotr J Bachul, Czesław Osuch, Ea-Sle Chang, et al.
Oncology Letters|August 28, 2019
Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in patients with advanced gastrointestinal stromal tumors treated with sunitinib after imatinib failurePaweł Sobczuk, Paweł Teterycz, Iwona Lugowska, et al.
Medical Oncology (Northwood, London, England)|November 13, 2013
What are the current outcomes of advanced gastrointestinal stromal tumors: who are the long-term survivors treated initially with imatinib?Piotr Rutkowski, Jolanta Andrzejuk, Elżbieta Bylina, et al.
Journal of Cancer Research and Clinical Oncology|April 27, 2007
Predictive factors for long-term effects of imatinib therapy in patients with inoperable/metastatic CD117(+) gastrointestinal stromal tumors (GISTs)Piotr Rutkowski, Zbigniew I Nowecki, Maria Debiec-Rychter, et al.
Annals of Surgical Oncology|May 3, 2007
Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumorPiotr Rutkowski, Zbigniew I Nowecki, Wanda Michej, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 23, 2020
The analysis of 3-year adjuvant therapy with imatinib in patients with high-risk molecular profiled gastrointestinal stromal tumors (GIST) treated in routine practicePiotr Rutkowski, Marcin Ziętek, Bożena Cybulska-Stopa, et al.
BMC Cancer|March 24, 2012
The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution studyPiotr Rutkowski, Elżbieta Bylina, Anna Klimczak, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 11, 2012
Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC- 99mTc/EDDA)NH2]-exendin-4 for the detection of insulinomaAnna Sowa-Staszczak, Dorota Pach, Renata Mikołajczak, et al.
Pageof 2